160 related articles for article (PubMed ID: 2778422)
61. Chlamydia trachomatis infection in women.
Faro S
J Reprod Med; 1985 Mar; 30(3 Suppl):273-8. PubMed ID: 4020784
[TBL] [Abstract][Full Text] [Related]
62. Short-course erythromycin therapy for endocervical chlamydia during pregnancy.
Thomason JL; Kellett AV; Gelbart SM; James JA; Broekhuizen FF
J Fam Pract; 1990 Jun; 30(6):711-2. PubMed ID: 2345341
[No Abstract] [Full Text] [Related]
63. [Chlamydia trachomatis cervicitis with right upper quadrant pain].
Sugase M; Minamizawa Y; Kaku S; Fujiwara T; Koizumi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1675-8. PubMed ID: 3681066
[No Abstract] [Full Text] [Related]
64. Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis.
Hooton TM; Batteiger BE; Judson FN; Spruance SL; Stamm WE
Antimicrob Agents Chemother; 1992 May; 36(5):1144-6. PubMed ID: 1510408
[TBL] [Abstract][Full Text] [Related]
65. The clinical experience with ofloxacin in the treatment of sexually transmitted diseases.
Corrado ML
Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1396-9. PubMed ID: 2031521
[TBL] [Abstract][Full Text] [Related]
66. Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin.
Paavonen J; Roberts PL; Stevens CE; Wølner-Hanssen P; Brunham RC; Hillier S; Stamm WE; Kuo CC; DeRouen T; Holmes KK
Am J Obstet Gynecol; 1989 Jul; 161(1):128-35. PubMed ID: 2502013
[TBL] [Abstract][Full Text] [Related]
67. The use and limitations of endocervical Gram stains and mucopurulent cervicitis as predictors for Chlamydia trachomatis in female adolescents.
Moscicki B; Shafer MA; Millstein SG; Irwin CE; Schachter J
Am J Obstet Gynecol; 1987 Jul; 157(1):65-71. PubMed ID: 2440306
[TBL] [Abstract][Full Text] [Related]
68. [Effects of levofloxacin once-a-day therapy on uterine cervicitis].
Mikamo H; Sato Y; Hayasaki Y; Tamaya T; Yamada Y; Ito K; Izumi K; Kawazoe K
Jpn J Antibiot; 1999 Jul; 52(7):511-6. PubMed ID: 10516931
[TBL] [Abstract][Full Text] [Related]
69. [Clinical studies on doxycycline treatment of urogenital Chlamydia trachomatis infections].
Tsunekawa T; Kumamoto Y; Sakai S; Hayashi K; Gohro T
Jpn J Antibiot; 1986 Jan; 39(1):17-23. PubMed ID: 3702057
[TBL] [Abstract][Full Text] [Related]
70. Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women.
Bowie WR; Manzon LM; Borrie-Hume CJ; Fawcett A; Jones HD
Am J Obstet Gynecol; 1982 Jan; 142(2):125-9. PubMed ID: 7055176
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of a seven day course of oxytetracycline in women with chlamydial cervicitis.
Hobson D; Arya OP; Rao PM; Lee N; Tait IA; Bradley MG; Mallinson H
Eur J Clin Microbiol; 1986 Oct; 5(5):591-5. PubMed ID: 3780714
[TBL] [Abstract][Full Text] [Related]
72. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
Wendel GD; Cox SM; Bawdon RE; Theriot SK; Heard MC; Nobles BJ
Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1390-6. PubMed ID: 2031520
[TBL] [Abstract][Full Text] [Related]
73. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis.
Sendağ F; Terek C; Tuncay G; Ozkinay E; Güven M
Aust N Z J Obstet Gynaecol; 2000 Feb; 40(1):44-7. PubMed ID: 10870778
[TBL] [Abstract][Full Text] [Related]
74. [Various therapeutic protocols used in genital disease caused by Chlamydia trachomatis].
Grima P; Romano A; Massa M; Tundo P
G Ital Chemioter; 1991; 38(1-3):157-8. PubMed ID: 1365577
[No Abstract] [Full Text] [Related]
75. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
[TBL] [Abstract][Full Text] [Related]
76. [Roxithromycin versus doxycycline in the treatment of cervicitis. Prospective randomized multicenter study under practice-related conditions].
Hoyme UB; Alimi M; Feldmann HU; Gerlach H; Keuter U; Marks HJ; Moayer M; Salih AF; Schindler AE; Stangier HJ
Fortschr Med; 1990 Apr; 108(12):244-6. PubMed ID: 2190897
[TBL] [Abstract][Full Text] [Related]
77. The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis.
Richmond SJ; Bhattacharyya MN; Maiti H; Chowdhury FH; Stirland RM; Tooth JA
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():149-53. PubMed ID: 3182458
[TBL] [Abstract][Full Text] [Related]
78. [Mucopurulent cervicitis].
Janier M; Viraben R; Vexiau-Robert D; Vernay-Vaïsse C; Passeron A; Dupin N;
Ann Dermatol Venereol; 2016 Nov; 143(11):759-761. PubMed ID: 27776812
[No Abstract] [Full Text] [Related]
79. Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome.
Nugent RP; Hillier SL
Sex Transm Dis; 1992; 19(4):198-202. PubMed ID: 1411834
[TBL] [Abstract][Full Text] [Related]
80. A phase-II study of trovafloxacin for the treatment of Chlamydia trachomatis infections.
Martin DH; Jones RB; Johnson RB
Sex Transm Dis; 1999 Aug; 26(7):369-73. PubMed ID: 10458628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
